FGF23 and type 2 diabetes mellitus: In this study, we examined a cohort of patients with type 2 diabetes using echocardiography and quantitative cardiac magnetic resonance imaging, and found that increased levels of FGF-23 were associated with reduced MPR, caused by a decrease in maximal MBF during pharmacological stress, and signs of impaired diastolic function.